Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip A Abarca

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Lung Cancer|July 18, 2017
Clinical Implications of the T790M Mutation in Disease Characteristics and Treatment Response in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)Daria Gaut, Myung Shin Sim, Yuguang Yue, et al.
Critical Reviews in Oncogenesis|June 10, 2016
Clinical Trials in Non-Small Cell Lung Cancer with Biomarker-Driven Treatment Allocation: Ready or Not, Here We ComeEdward B Garon, Phillip A Abarca, Jennifer L Strunck, et al.
Computers in Biology and Medicine|January 26, 2015
Representing and extracting lung cancer study metadata: study objective and study designJean I Garcia-Gathright, Andrea Oh, Phillip A Abarca, et al.
Cancer|November 11, 2017
Non-small cell lung cancer clinical trials requiring biopsies with biomarker-specific results for enrollment provide unique challengesMarshall L Spiegel, Jonathan W Goldman, Brian R Wolf, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Lung Cancer|July 18, 2017
Clinical Implications of the T790M Mutation in Disease Characteristics and Treatment Response in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)Daria Gaut, Myung Shin Sim, Yuguang Yue, et al.
Critical Reviews in Oncogenesis|June 10, 2016
Clinical Trials in Non-Small Cell Lung Cancer with Biomarker-Driven Treatment Allocation: Ready or Not, Here We ComeEdward B Garon, Phillip A Abarca, Jennifer L Strunck, et al.
Computers in Biology and Medicine|January 26, 2015
Representing and extracting lung cancer study metadata: study objective and study designJean I Garcia-Gathright, Andrea Oh, Phillip A Abarca, et al.
Cancer|November 11, 2017
Non-small cell lung cancer clinical trials requiring biopsies with biomarker-specific results for enrollment provide unique challengesMarshall L Spiegel, Jonathan W Goldman, Brian R Wolf, et al.
Pageof 1